Cancer Associated Thrombosis and Isoquercetin (CATIQ)

NCT02195232 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jeffrey Zwicker, MD

Collaborators